GP-1 antigen vaccine (GlaxoSmithKline)

N/A

Report date: 2025/03/20 15:11:12

Base Information

Drug NameGP-1 antigen vaccine (GlaxoSmithKline)
Drug Alias NameStaphylococcus epidermidis GP-1 vaccine (Nabi)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVaxart Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcVaxart Inc
Active IndicationsN/A
Inactive IndicationsStaphylococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A